Treatment of azoospermia with plasma rich growth factors

investigation of the effect of Plasma Rich Growth Factor (PRGF) in treatment of patient with azoospermia

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140911019125N2

Enrollment

Registered

2019-02-21

Start date

2019-02-20

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility treatment. Other specified disorders of male genital organs

Interventions

In this study, own of the patient's blood derivatives (Platelet rich growth factors/PRGF) is used. This product is injected 3 times at intervals of 2 weeks to patients..

Eligibility

Sex/Gender

Male

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient with non-obstructive azoospermia Signs of maturation arrest in testis biopsy patients aged between 20-65 years

Exclusion criteria

Exclusion criteria: Patients with obstructive azoospermia Patients with pervious testis surgery Males with genital tract infection or anatomical abnormalities Patients with severe medical problems Chromosomal abnormality Present of Sertoli cell only syndrome in biopsy of testis

Design outcomes

Primary

Measure	Time frame
Investigation and increasing in sperms in spermogram. Timepoint: Before intervention and 3, 6 months after intervention. Method of measurement: Microscopic measurment.;Investigation and improvement in spermatogenesis in biopsy. Timepoint: Before intervention and 3 , 6 months after intervention. Method of measurement: Microscopic measurment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Farsinejad

Kerman University of Medical Sciences

afarsinejad@kmu.ac.ir+98 34 3132 5374

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026